Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 3Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Prostatic Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Hand-Foot Syndrome 1Colorectal Neoplasms 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 17Surveys and Questionnaires 15pembrolizumab 14Specimen Handling 10Radiotherapy 10Early Intervention, Educational 10Zoledronic Acid 9Interviews as Topic 9olaparib 8Standard of Care 8Psychiatric Rehabilitation 8Therapeutics 7Magnetic Resonance Spectroscopy 7Gemcitabine 7Fulvestrant 7durvalumab 6Paclitaxel 6Nivolumab 6Methods 6Educational Status 6Carboplatin 6enzalutamide 5Trastuzumab 5Radiosurgery 5Exercise 5Cyclophosphamide 5palbociclib 4Taxes 4Sirolimus 4Letrozole 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Tobacco Use Cessation Devices × Breast × Clear all
NCT01434342 2021-09-28

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Completed
146 enrolled 10 charts
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Tobacco Use Disorder, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡